Body mass index is a prognostic factor in adult patients with acute myeloid leukemia

Body mass index (BMI), which represents the proportion of weight to height, is a controversial prognostic factor for acute myeloid leukemia (AML). We evaluated prognostic value of BMI in Japanese AML. The study included 369 adult patients with newly diagnosed AML who were administered either daunoru...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology 2017-05, Vol.105 (5), p.623-630
Main Authors: Ando, Taiki, Yamazaki, Etsuko, Ogusa, Eriko, Ishii, Yoshimi, Yamamoto, Wataru, Motohashi, Kenji, Tachibana, Takayoshi, Hagihara, Maki, Matsumoto, Kenji, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Fujita, Hiroyuki, Kanamori, Heiwa, Fujisawa, Shin, Nakajima, Hideaki
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Antineoplastic Agents - administration & dosage
Body Mass Index
Cytarabine - administration & dosage
Daunorubicin - administration & dosage
Female
Hematology
Humans
Idarubicin - administration & dosage
Induction Chemotherapy
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - mortality
Male
Medicine
Medicine & Public Health
Middle Aged
Multivariate Analysis
Oncology
Original Article
Prognosis
Survival Rate
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Body mass index (BMI), which represents the proportion of weight to height, is a controversial prognostic factor for acute myeloid leukemia (AML). We evaluated prognostic value of BMI in Japanese AML. The study included 369 adult patients with newly diagnosed AML who were administered either daunorubicin or idarubicin with cytarabine as induction chemotherapy. The patients were categorized into two groups according to their BMI: the NW group (BMI 
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-017-2183-7